Partner Content Partner Content Hear the Keynote Addresses from MedImmune and Spirogen this ... Antibodies & Antibody Drug Conjugates
Partner Content Partner Content Explore the ADC component hazards, risks and safety project ... ADC Summit
Partner Content Partner Content Pfizer presents the opening keynote at the SMi’s ADC Confere... ADC Summit 2018
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
